Skip to main content
. Author manuscript; available in PMC: 2021 Sep 25.
Published in final edited form as: Pediatr Res. 2020 Sep 16;90(2):359–365. doi: 10.1038/s41390-020-01162-2

Table 1:

Neonatal Cohort Demographics and Clinical Characteristics by BPD Status

Neonatal Characteristics No-Mild BPD (n=57)
n (%)
Moderate-to-Severe BPD (n=30)
n (%)
p-value
Gestational Age (wks ±SD) 28.9 ±2.0 26.7 ±2.0 <0.001
Birth Weight (g ±SD) 1220 ±347 781 ±257 <0.001
Male 31 (54.4) 11 (36.7) 0.116
Prenatal Steroids 47 (82.5) 21 (70.0) 0.181
Maternal Chorioamnionitis 7 (12.3) 2 (6.7) 0.713
Surfactant 20 (35.1) 26 (86.7) <0.001
Neonatal Surgery 2 (3.5) 11 (36.7) <0.001
NEC 1 (1.8) 4 (13.3) 0.046
PDA 23 (40.4) 24 (80.0) <0.001
Infection 22 (38.6) 21 (70.0) 0.005
WMI 3 (5.3) 7 (23.3) 0.028
IVH Grade 3 or 4 1 (1.8) 5 (16.7) 0.017
CbH 17 (29.8) 12 (40.0) 0.339

BPD: bronchopulmonary dysplasia; SD: standard deviation; NEC: necrotizing enterocolitis; PDA: patent ductus arteriosus; WMI: white matter injury; IVH: intraventricular hemorrhage; CbH: cerebellar hemorrhage